Koyfin Home > Directory > Health Care > Adverum Biotechnlgs

Adverum Biotechnlgs Price Chart ADVM

Historical daily share price chart and data for Adverum Biotechnlgs since 2014 adjusted for splits and dividends. The latest closing price for Adverum Biotechnlgs as of October 22, 2020 is $12.29.
  • In 2020 the stock opened at $11.60 and closed at $12.29 for a gain of 6% YTD.
  • In 2019 the stock opened at $3.07 and closed at $11.52 for a gain of 73%.
  • In 2018 the stock opened at $3.65 and closed at $3.15 for a loss of -16%.
  • In 2017 the stock opened at $3.00 and closed at $3.50 for a gain of 14%.
View Chart On Koyfin

Adverum Biotechnlgs Summary

Stock Symbol: ADVM

Adverum Biotechnlgs Company Info

Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, engages in developing gene therapy product candidates to treat ocular and rare diseases. Its pipeline of product candidates includes ADVM-022, an adeno- associated virus (AAV). 7m8-aflibercept for the treatment of wet age-related macular degeneration; ADVM-043, an investigational gene therapy candidate for the treatment of alpha-1 antitrypsin deficiency; and ADVM-053, a preclinical gene therapy product candidate for the treatment of hereditary angioedema. The company has collaboration agreements with Editas Medicine, Inc. to leverage its proprietary AAV vectors for genome editing technologies to treat up to five inherited retinal diseases; and Regeneron Pharmaceuticals, Inc. for the development of up to eight distinct ocular therapeutic targets. The company was formerly known as Avalanche Biotechnologies, Inc. and changed its name to Adverum Biotechnologies, Inc. in May 2016. Adverum Biotechnologies, Inc. was founded in 2006 and is headquartered in Redwood City, California.
Market Cap
Dividend Yield
0 %
Beta vs SPX
Short Interest
1240.34 %
30D Volatility
Hedge Fund Held
0 %

Last 10 Days of ADVM Prices